Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/30/15 → 3/25/21 |
Funding
- Quintiles Inc: $83,043.00
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis
- Flomenhoft, Deborah (PI)